Free for a Fee

A recent trend towards compulsory licensing has also raised red flags for many. In March 2012, the Indian Patent Office granted the country’s first compulsory license to a domestic pharmaceutical company for a cancer drug developed by Bayer AG. At a time when India’s economy is climbing to new heights and foreign investors are interested in entering the market, some find the fact that the Indian government would essentially commandeer foreign IP to be threatening.

The post India seeks more foreign investment but throttles IP rights through compulsory licensing appeared first on IPWatchdog.com | Patents & Patent Law.

The content in this post was found at http://www.ipwatchdog.com/2015/06/24/india-seeks-more-foreign-investment-but-throttles-ip-rights-through-compulsory-licensing/id=58964/ and was not authored by the moderators of freeforafee.com. Clicking the title link will take you to the source of the post.